The 2024 Q2 earnings season is slowly grinding to a halt, with the majority of S&P 500 companies already delivering quarterly results. And during the period, these three companies stole the spotlight.
A handful of stocks benefited massively during the pandemic. It was an interesting time to be an investor, to say the least, and those who targeted the stay-at-home stocks were rewarded handsomely with considerable gains.
Let's delve into some of the best ETF charts of Q2 earnings.
With NVIDIA Corporation NVDA earnings in focus this week, analysts highlight key trends including the rise of artificial intelligence, strong demand from China, and geopolitical restrictions as crucial drivers for the semiconductor industry.
The stock market has continued to perform well, with the NASDAQ leading the way in terms of total returns in recent years.
Our thesis in January has largely played out as expected, as recent product launches have catalyzed higher stock prices and better financial results. We think the company is stronger than ever, and well positioned to continue delivering solid growth on both the top and bottom lines. With a futures offering in the pipeline and a strong management vision, Robinhood remains a compelling investment opportunity.
Rose's Income Garden has been active for 2.75 years with 85 stocks and a current yield of 6.3%. RIG has a total return of 12.08% YTD, outperforming SPY by 6.77% since inception on November 22, 2021. Evaluation of 48 common stocks based on EPS yield, P/E, and Chowder# metrics to identify winners for investment.
Discretionary stocks like Royal Caribbean Cruises Ltd. (RCL), Interface, Inc. (TILE), Cinemark Holdings, Inc. (CNK) and Traeger, Inc. (COOK) are poised to gain once the Fed starts its rate cuts.
Lower rates could kick-start the slow real estate market, boosting companies like Redfin. With a deposit base that has grown rapidly, SoFi could be a big winner of lower funding costs.
AI is a massive opportunity, but you don't need to buy individual AI stocks to take advantage. I'm not particularly AI-savvy, so I'm going to use two ETFs to get AI exposure in my portfolio instead.
AI stocks have sold off since mid-July. Fears over a recession and AI's true usefulness have led to a sharp pullback.
For Fifth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 Scholarship LAVAL, QC / ACCESSWIRE / August 13, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the recipients of its 2024 Salix Gastrointestinal Health Scholars Program. For the fifth year, Bausch Health is proud to award 10 deserving students living with a GI disease $10,000 each to further their higher education.